就职 发表于 2025-3-26 23:49:01

Md Akbar,Hasan Ali,Shweta Srivastav,Kainat Alam,Shipra Daniel,Faraat Ali

寻找 发表于 2025-3-27 01:54:48

http://reply.papertrans.cn/43/4284/428312/428312_32.png

苦笑 发表于 2025-3-27 06:11:45

http://reply.papertrans.cn/43/4284/428312/428312_33.png

高原 发表于 2025-3-27 12:20:10

Conventional to Nanoscale-Based Carrier Systems in the Management of Ovarian Cancer,ability, and prolonged therapeutic regimen. Thus, to overcome these limitations nanotherapeutic approaches can be used for the effective delivery of drugs with superior targetability and negligible or no toxicity. In this chapter, we have discussed the major molecular pathways and cellular targets c

enormous 发表于 2025-3-27 15:05:34

http://reply.papertrans.cn/43/4284/428312/428312_35.png

值得尊敬 发表于 2025-3-27 18:29:52

http://reply.papertrans.cn/43/4284/428312/428312_36.png

adumbrate 发表于 2025-3-27 22:32:45

http://reply.papertrans.cn/43/4284/428312/428312_37.png

高度 发表于 2025-3-28 05:59:51

http://reply.papertrans.cn/43/4284/428312/428312_38.png

抱负 发表于 2025-3-28 06:46:41

Neuroendocrine Carcinoma of Endometrium Convention Treatment Approach to Nanomedicine,e female genital tract are aggressive and rare tumours that usually involve the cervix and ovary, and are seen rarely in the endometrium in perimenopausal or postmenopausal women But, their prospective role in gNECs still remains uncertain because of the small prevalence. Few subjective proofs exist

Mitigate 发表于 2025-3-28 12:20:24

http://reply.papertrans.cn/43/4284/428312/428312_40.png
页: 1 2 3 [4] 5 6
查看完整版本: Titlebook: Hormone Related Cancer Mechanistic and Nanomedicines; Challenges and Prosp Mahfoozur Rahman,Waleed H Almalki,Khalid S Alharbi Book 2022 The